Filing Details
- Accession Number:
- 0001140361-11-023676
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-28 13:00:00
- Reporting Period:
- 2011-04-26
- Filing Date:
- 2011-04-28
- Accepted Time:
- 2011-04-28 16:17:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408555 | B. William Goodspeed | One Idexx Drive Westbrook ME 04092 | Corporate Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-26 | 5,082 | $56.95 | 9,702 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-26 | 3,158 | $53.31 | 12,860 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-26 | 8,298 | $34.37 | 21,158 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-26 | 5,265 | $56.95 | 26,423 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-26 | 2 | $34.37 | 26,425 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-04-26 | 21,805 | $79.42 | 4,620 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-04-26 | 5,082 | $0.00 | 5,082 | $56.95 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-04-26 | 3,158 | $0.00 | 3,158 | $53.31 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-04-26 | 8,298 | $0.00 | 8,298 | $34.37 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-04-26 | 5,265 | $0.00 | 5,265 | $56.95 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-04-26 | 2 | $0.00 | 2 | $34.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,386 | 2015-02-13 | No | 4 | M | Direct | |
| 10,754 | 2017-02-13 | No | 4 | M | Direct | |
| 9,539 | 2016-02-13 | No | 4 | M | Direct | |
| 3,510 | 2015-02-13 | No | 4 | M | Direct | |
| 2,911 | 2016-02-13 | No | 4 | M | Direct |
Footnotes
- Includes 89 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/31/2011.
- Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.
- Grant of options to buy shares of common stock becomes exercisable as to 3,158 shares on 02/14/2011 and 02/14/2012, 3,157 shares on 02/14/2013 and 02/14/2014, and the remaining 1,282 shares on 02/14/2015.
- Grant of options to buy shares of common stock becomes exercisable as to 4,149 shares on 02/14/2010, 02/14/2011, 02/14/2012 and 02/14/2013, and the remaining 1,241 shares on 02/14/2014.
- Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010, 02/14/2011, 02/14/2012 and 02/14/2013, and the remaining 2,909 shares on 02/14/2014.
Billionaire Hedge Funds
